A randomized controlled clinical study on the Superiority of Feng's steam therapy in the treatment of dyslipidemia

Phase 1

Recruiting

• Conditions: Dyslipidemia

• Registration Number: ITMCTR2000003916
• Lead Sponsor: Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) Meet the diagnostic criteria of Western medicine for hypercholesterolemia or mixed hyperlipidemia;
(2) TCM differentiation is the syndrome of damp turbid arthralgia;
(3) Aged over 18 and under 75;
(4) Sign the informed consent form.

Exclusion Criteria

(1) Patients who have suffered from acute myocardial infarction, cerebrovascular accident, severe trauma, post-PCI or other major surgery within six months and need to take lipid-lowering drugs for a long time;
(2) Patients with acute coronary syndrome;
(3) Those with secondary hyperlipidemia caused by nephrotic syndrome, hypothyroidism, gout, acute or chronic hepatobiliary disease, diabetes, etc.;
(4) Hyperlipidemia caused by drugs (phenothiazines, ß-receptor blockers, adrenal corticosteroids, and certain contraceptives, etc.) or who are using heparin, thyroxine therapy drugs and other drugs that affect blood lipid metabolism patient;
(5) Combined with serious primary diseases such as liver, kidney and hematopoietic system;
(6) Pregnant or lactating women or those who plan to become pregnant during the trial period or whose spouse plans to become pregnant;
(7) Those who are allergic or may be allergic to this treatment;
(8) Patients with heart failure and heart function >= NYHA III; combined with severe arrhythmia (such as frequent ventricular premature, ventricular tachycardia, rapid atrial fibrillation, etc.) or other severe or unstable heart, liver, kidney, endocrine, Patients with medical diseases such as blood;
(9) Patients with uncontrolled grade 3 hypertension (sitting diastolic blood pressure >= 110mmHg or systolic blood pressure >= 180mmHg;
(10) People with mental illness, alcohol or drug dependence;
(11) Patients with liver and kidney damage, ALT >= 1.5N, Cr > 1N (N is the upper limit of normal);
(12) Those with a history of malignant tumors or related diseases;
(13) Subjects participated in other clinical trials within 1 month;
(14) People with infectious skin diseases or skin injuries;
(15) Any other situation that the investigator believes will affect the efficacy and safety of the trial drug treatment.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
High density lipoprotein cholesterol;Triglycerides;LDL cholesterol;Total cholesterol;